The recent anti-clotting drug is known to beat Plavix with the content of ticagrelor or Brilinta in it. Thisis supposed to be really relieving in terms of controlling heart attack and is supposed to be working

better than clopidogerol. The new discovery has been effective in making reduction in death rates. The new study is really effective in treating heart attacks and controlling other coronary syndromes.

The treatment with clopidogrel is quite widely accepted in the use of treatment of heart oriented problems of the serious kind.

Dr. Robert A. Harrington, the director of the Duke Clinical Research Institute at Duke University, had been looking for a serious antiplatelet agent that would totally reduce conditions for heart patients.

Dr. Lars Wallentin, professor of cardiology at the Uppsala Clinical Research Center, Sweden, has also seen that patients improve far better on the new alternative.

The standard medicine is thus paving way for something even better giving really good results. The Swedish researchers have been working with the improvement factor in the myocardial infarction from the new medicine. The replacement of the standard ones has been reporting some really wonderful results. Cardiologists in the Cardiology Congress, Barcelona, have also reported on the same results. PLATO or Platelet Inhibition and Patient Outcomes had randomly studied 18,624 with the ticagreolar process or the clopidogrel.